retatrutide nonalcoholic fatty liver disease trial nash Researchers report promising results with retatrutide, which significantly reduced fat in some patients over several months. Excess liver fat causes metabolic dysfunction–associated steatotic retatrutide liver fat reduction nonalcoholic

Muchas veces disminuye el deseo del consumo de alcohol

Not sharing cooking utensils such as knives and chopping boards when cutting foods

Although use of these products is generally considered safe and well-tolerated, further research is needed to assess any long-term effects

It is not FDA-approved for obesity or chronic weight management

PMC: Comparative Safety of GLP-1/GIP Co-Agonists Versus GLP-1 Receptor Agonists for Weight Loss. New England Journal of Medicine: Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. PMC: Who Wins the Battle Against Obesity

With ongoing guidance and personalized care, the team helps patients feel comfortable, informed, and prepared as they begin their weight loss journey